Malignant liver tumours include a wide range of primary and secondary tumours. Although
surgery remains the mainstay of curative treatment, modern therapies integrate a variety of …

Abstract Purpose of Review Cholangiocarcinoma is a rare biliary adenocarcinoma
associated with poor outcomes. Cholangiocarcinoma is subdivided into extrahepatic and …

Biliary tract cancer, or cholangiocarcinoma, arises from the biliary epithelium of the small
ducts in the periphery of the liver (intrahepatic) and the main ducts of the hilum …

Currently, the only curative treatment for cholangiocarcinoma (CCA) is surgical resection,
though this treatment is possible in less than 40% of patients. However, recent …

Simple Summary Intrahepatic cholangiocarcinoma is an aggressive primary liver cancer
originating in the intrahepatic bile ducts. While surgical resection is the only curative …

Background Late-stage or recurrent intrahepatic cholangiocarcinoma (ICC) patients exhibit
poor prognosis due to limited sensitivity to chemotherapy or radiotherapy and coexistence of …

Cholangiocarcinoma (CCA) is a relatively rare malignant tumor originating from the bile duct
epithelial cells, and it is one of the malignant tumors with fast growth in incidence and death …

Purpose Non-resectable cholangiocarcinoma (CCC) is a significant therapeutic challenge
because of bad prognosis. This study analyzed the outcome after SBRT for intra-and …

Introduction: Intrahepatic cholangiocarcinoma (iCCA) is a malignancy with an increasing
incidence and a high-case fatality. While surgery offers the best hope at long-term survival …

Background To evaluate the role of ablative radiotherapy doses in the treatment of hilar or
intrahepatic cholangiocarcinoma (CCC) using stereotactic body radiotherapy (SBRT) …